Lynn D. Bleil has served as a member of the Board since September 2018. Ms. Bleil led the West Coast Healthcare Practice of McKinsey & Company and was a core leader of McKinsey’s worldwide Healthcare Practice before her retirement as a Senior Partner in 2013 after 25 years at the firm. Currently, Ms. Bleil serves as a member of the Board of Directors at Stericycle, Inc. and Sonova Holding AG, and has been nominated to serve on the Board of Alcon Inc. upon its spin off from Novartis AG in Spring 2019. She is also a strategic advisor to private companies Halo Neuroscience and Navigen Pharamaceuticals, and serves on the Governing Board of Intermountain’s Park City Medical Center, a non-profit healthcare organization. Her prior directorships included DST Systems, Inc. and Auspex Pharmaceuticals. Ms. Bleil received her B.S.E. in Chemical Engineering from Princeton University and her M.B.A. from the Stanford Graduate School of Business.
Ms. Bleil serves as member of the Nominating and Governance Committee and as member of the Compensation and Leadership Development Committee.